U.S. flag

An official website of the United States government

NM_001114753.3(ENG):c.1088G>A (p.Cys363Tyr) AND ENG-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 12, 2024
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003984260.2

Allele description [Variation Report for NM_001114753.3(ENG):c.1088G>A (p.Cys363Tyr)]

NM_001114753.3(ENG):c.1088G>A (p.Cys363Tyr)

Gene:
ENG:endoglin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.11
Genomic location:
Preferred name:
NM_001114753.3(ENG):c.1088G>A (p.Cys363Tyr)
HGVS:
  • NC_000009.12:g.127824350C>T
  • NG_009551.1:g.35419G>A
  • NM_000118.4:c.1088G>A
  • NM_001114753.3:c.1088G>AMANE SELECT
  • NM_001278138.2:c.542G>A
  • NM_001406715.1:c.1088G>A
  • NP_000109.1:p.Cys363Tyr
  • NP_000109.1:p.Cys363Tyr
  • NP_001108225.1:p.Cys363Tyr
  • NP_001108225.1:p.Cys363Tyr
  • NP_001265067.1:p.Cys181Tyr
  • NP_001393644.1:p.Cys363Tyr
  • LRG_589t1:c.1088G>A
  • LRG_589t2:c.1088G>A
  • LRG_589:g.35419G>A
  • LRG_589p1:p.Cys363Tyr
  • LRG_589p2:p.Cys363Tyr
  • NC_000009.11:g.130586629C>T
  • NM_000118.3:c.1088G>A
  • NM_001114753.1:c.1088G>A
  • NM_001114753.2:c.1088G>A
Protein change:
C181Y
Molecular consequence:
  • NM_000118.4:c.1088G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001114753.3:c.1088G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278138.2:c.542G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406715.1:c.1088G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
ENG-related disorder
Synonyms:
ENG-related condition; ENG-Related Disorders
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004797946PreventionGenetics, part of Exact Sciences
no assertion criteria provided
Pathogenic
(Jul 12, 2024)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004797946.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The ENG c.1088G>A variant is predicted to result in the amino acid substitution p.Cys363Tyr. This variant has been reported in a patient with hereditary hemorrhagic telangiectasia (HHT) (Paquet et al. 2001. PubMed ID: 11440987). This variant disrupts a cysteine residue within ENG, and functional studies of this variant showed that it led to protein misfolding and retention within the endoplasmic reticulum (Ali et al. 2011. PubMed ID: 22022569). This variant has not been reported in gnomAD, indicating this variant is rare. In addition, other variants impacting the same amino acid (p.Cys363Ser and p.Cys363Trp) have also been reported in patients with HHT (Bossler et al. 2006. PubMed ID: 16752392; Supplemental Table, Nishida. 2012. PubMed ID: 22991266; Kitayama et al. 2021. PubMed ID: 34872578). Based on this evidence, we interpret the c.1088G>A (p.Cys363Tyr) variant as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024